Company intelligence / Profile preview

EXBIO

Vestec, Středočeský kraj, Czech Republic

Ownership: Private
Employees: ~50
Development stage: Other

Overview

EXBIO produces and supplies a large commercial portfolio of monoclonal and polyclonal antibodies and reagents primarily for research and in vitro diagnostic (IVD) use in flow cytometry, including CE-IVD labeled products for clinical laboratories outside the USA and Canada. Their products are widely recognized among life science researchers and diagnostic laboratories, and some are validated for OEM and contract manufacturing.

Therapeutic areas: HematologyOncologyImmunologyOther
Modalities: Monoclonal antibodyPolyclonal antibodyFluorochrome-conjugated antibodyProtein
Industry: Protein Biomarker Diagnostics

Partnerships

OEM supply and catalog partnerships with global antibody suppliersIn-licensing from world-wide universities and research institutions

Beyond the preview

Go deeper on EXBIO.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on EXBIO.

Explore the full profile